Quantcast

Latest genomics Stories

2014-06-30 12:32:32

--CHOP Study: Patients with Specific Gene Variants May Require Higher Doses of Pain-Control Drugs-- PHILADELPHIA, June 30, 2014 /PRNewswire-USNewswire/ -- In the first genome-wide analysis of postsurgical pain in children, pediatric researchers identified variations in genes that affect a child's need for pain-control drugs. The findings suggest that at some point physicians may calibrate pain-medication dosages according to a child's individual genetic makeup....

2014-06-28 23:01:17

This metabolomics industry 2014-2019 research report, available with LifeScienceIndustryResearch.com is segmented based on techniques, applications, indications, geographic regions, and countries. It says the global metabolomics market was valued at $565 million in 2014 and is expected to grow at a CAGR of 30% from 2014 to 2019. Dallas, TX (PRWEB) June 28, 2014 Metabolomics Market by Technique (Gas Chromatography, High Performance Liquid Chromatography, Nuclear Magnetic Resonance...

2014-06-25 23:14:52

Genomics R&D firm, Ryogen LLC, receives a patent, its 30th, for polynucleotides related to tumor-suppressing subtransferable candidate 4. Suffern, N.Y. (PRWEB) June 25, 2014 Ryogen LLC, a genomics R&D company focusing on polynucleotide sequences implicated in human diseases, was awarded a new patent, bringing the total number of U.S. Patents issued to Ryogen to 30. U.S. Patent No. 8,722,865, titled “Isolated genomic polynucleotide fragments from p15 region of chromosome 11...

2014-06-25 12:30:18

HLI Co-Founder, Robert Hariri Speaks on Medical Innovation at 2014 BIO International Convention in San Diego LA JOLLA, Calif., June 25, 2014 /PRNewswire/ -- Human Longevity, Inc. (HLI), a genomics and cell therapy-based diagnostic and therapeutic company focused on extending the healthy, high performance human life span, today called on physicians, the insurance industry and political leaders to support promising new avenues of medical discovery on behalf of patients with...

2014-06-25 08:28:04

Report Highlights 113 Products, a 57 Percent Increase in the Last Three Years WASHINGTON, June 25, 2014 /PRNewswire-USNewswire/ -- The Personalized Medicine Coalition (PMC) announced today the release of the fourth edition of the organization's signature document, The Case for Personalized Medicine. http://photos.prnewswire.com/prnvar/20130517/DC16280LOGO The report notes the steady development of the personalized medicine field, with a 57 percent increase in products the last three years. In...

2014-06-24 23:05:24

Transparency Market Research published a new report "Molecular Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" to its report store. Browse the full report: http://www.transparencymarketresearch.com/molecular-diagnostics-industry.html Albany, New York (PRWEB) June 24, 2014 According to a new market report published by Transparency Market Research "Molecular Diagnostics Market (PCR, Next Generation Sequencing, Microarray,...

2014-06-24 23:05:08

GIA announces the release of a comprehensive global report on Genetic Testing markets. Global market for Genetic Testing is forecast to reach US$7.3 billion by 2020, driven by growing healthcare awareness, growing interest in genetic testing for accurate disease diagnosis and treatment decision-making, and favorable reimbursement coverage policies. San Jose, California (PRWEB) June 24, 2014 Follow us on LinkedIn – Almost every known disease, ranging from common maladies to...

2014-06-24 11:02:30

Virginia Tech Exploiting individual genomes for personalized medicine may be more complicated than medical scientists have suspected, researchers at Virginia Bioinformatics Institute have discovered. In a paper published in June in the journal Aging, scientists from the institute's Medical Informatics and Systems Division found that spontaneous mutations occur in our bodies constantly, but the rate of change differed dramatically among various people. The study has implications for...

2014-06-24 08:29:42

Pharmacogenomic test now available to help guide clinicians' medication decisions for veterans being treated for mental health conditions MASON, Ohio, June 24, 2014 /PRNewswire/ -- Assurex Health today announced that the U.S. Department of Veterans Affairs (VA) has approved its Federal Supply Schedule (FSS) contract as a government supplier, effective June 15, 2014, making the GeneSight(®) Psychotropic test available for use in VA facilities nationwide. The Veterans Health...

2014-06-23 12:29:40

ANZAC Research Institute uses NextCODE's diagnostics and discovery solutions to mine entire genomes for novel mutations in X-linked Charcot-Marie-Tooth syndrome CAMBRIDGE, Mass., June 23, 2014 /PRNewswire/ -- NextCODE Health today announced that a team at the ANZAC Research Institute in Sydney, Australia have used NextCODE capabilities to home in on novel sequence variants underlying X-linked Charcot-Marie-Tooth syndrome (CMTX). CMTX is a rare and progressively debilitating...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related